{"id":1678,"date":"2021-08-11T11:45:13","date_gmt":"2021-08-11T09:45:13","guid":{"rendered":"https:\/\/peptides.sk\/?post_type=product&p=1678"},"modified":"2021-08-16T12:10:26","modified_gmt":"2021-08-16T10:10:26","slug":"revilab-peptide-ml-02","status":"publish","type":"product","link":"https:\/\/peptides.sk\/product\/revilab-peptide-ml-02\/","title":{"rendered":"Revilab Peptide ML 02\u00a0"},"content":{"rendered":"
Revilab Peptide ML 02\u00a0<\/strong>\u2014 for hematopoietic system, chemoradioprotector.<\/p>\n Recommended for<\/strong>:<\/p>\n \u2022 with anemia of different genesis <\/p>\n Igredients<\/strong><\/p>\n MCC (carrier), capsule (gelatin, HPMC, food titan dye dioxide), lactose (filler), omega-3 polyunsaturated fatty acids (alpha-linoleic acid, contains carrier sorbitol and maltodextrin), mixture of tocopherols (vitamin E), peptide complex AA-3 (dipeptide consisting of L-lysine and L-glumatic acid), peptide complex AA-2 (tripeptide consisting of L-glutamic acid, L-aspartic acid and L-proline), peptide complex AA-10 (tripeptide consisting of L-glutamic acid, L-aspartic acid and L-leucine), calcium stearate (the flowing agent), silicon dioxide (the flowing agent), pyridoxine hydrochloride (vitamin B6<\/sub>), peptide complex AA-4 (heptapeptide consisting of L-serine, L-alanine, L-glutamic acid, L-lysine, folic acid (vitamin B9<\/sub>).<\/p>\n <\/p>\n Application<\/strong><\/p>\n Adults 1 tablet a day during mealtimes. Duration\u00a0\u2014 4\u20136 weeks. If necessary, you can repeat. Possible re receptions throughout the year.<\/p>\n","protected":false},"excerpt":{"rendered":" Revilab Peptide ML 02\u00a0\u2014 for hematopoietic system, chemoradioprotector. Recommended for: \u2022 with anemia of different genesis \u2022 for violations of the hematopoietic system \u2022 with varicose veins \u2022 with arteriosclerosis of blood vessels \u2022 with trophic ulcers \u2022 with thrombophlebitis \u2022 with angiopathy \u2022 to improve immunity \u2022 with a metabolic disorder \u2022 in the […]<\/p>\n","protected":false},"featured_media":2232,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false},"product_cat":[66],"product_tag":[],"acf":[],"_links":{"self":[{"href":"https:\/\/peptides.sk\/wp-json\/wp\/v2\/product\/1678"}],"collection":[{"href":"https:\/\/peptides.sk\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/peptides.sk\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/peptides.sk\/wp-json\/wp\/v2\/comments?post=1678"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/peptides.sk\/wp-json\/wp\/v2\/media\/2232"}],"wp:attachment":[{"href":"https:\/\/peptides.sk\/wp-json\/wp\/v2\/media?parent=1678"}],"wp:term":[{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/peptides.sk\/wp-json\/wp\/v2\/product_cat?post=1678"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/peptides.sk\/wp-json\/wp\/v2\/product_tag?post=1678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n\u2022 for violations of the hematopoietic system
\n\u2022 with varicose veins
\n\u2022 with arteriosclerosis of blood vessels
\n\u2022 with trophic ulcers
\n\u2022 with thrombophlebitis
\n\u2022 with angiopathy
\n\u2022 to improve immunity
\n\u2022 with a metabolic disorder
\n\u2022 in the complex treatment of cancer patients
\n\u2022 Improved tolerability of chemoradiotherapy
\n\u2022 increase of organism resistance to intoxication, infections<\/p>\n